SIC
RLAY icon

SJS Investment Consulting’s Relay Therapeutics RLAY Stock Holding History

SJS Investment Consulting’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$599 Buy
+32
New +$465 ﹤0.01% 2206
2023
Q4 		– Sell
-4
Closed -$34 – 1639
2023
Q3 		$34 Hold
4
– – ﹤0.01% 1607
2023
Q2 		$51 Buy
4
+2
+100% +$25 ﹤0.01% 1559
2023
Q1 		$33 Buy
+2
New +$36 ﹤0.01% 1547
2022
Q4 		– Sell
-2
Closed – – 1685
2022
Q3 		$0 Buy
+2
New +$44 ﹤0.01% 1465

Other funds holding RLAY

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

SJS Investment Consulting's RLAY Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 32 shares worth $599. The stake represents ﹤0.01% of the portfolio and ranks #2206 among its holdings. This is a return to the name: SJS Investment Consulting previously reported a position in RLAY as recently as Q3 2023.

SJS Investment Consulting first reported a position in RLAY in Q3 2022 and has held it in 5 quarters since. 28 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • SJS Investment Consulting held 32 shares of Relay Therapeutics worth $599 as of Q2 2026.
  • Relay Therapeutics was a new SJS Investment Consulting position in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2206 holding.
  • SJS Investment Consulting first reported a position in Relay Therapeutics in Q3 2022 and has held it in 5 quarters since.
  • 28 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.